{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T05:08:55Z","timestamp":1768885735591,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ijrobp.2016.06.2456","type":"journal-article","created":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T20:07:13Z","timestamp":1475179633000},"page":"645-652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Methods for Reducing Normal Tissue Complication Probabilities in Oropharyngeal Cancer: Dose Reduction or Planning Target Volume Elimination"],"prefix":"10.1016","volume":"96","author":[{"given":"Stuart E.","family":"Samuels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avraham","family":"Eisbruch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Vineberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Choonik","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha M.","family":"Matuszak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall K.","family":"Ten Haken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristy K.","family":"Brock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2016.06.2456_bib1","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the united states","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib3","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1200\/JCO.2011.38.4099","article-title":"Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer","volume":"30","author":"Gillison","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib4","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1002\/cncr.28250","article-title":"Long-term prognosis and risk factors among patients with HPV-associated oropharyngeal squamous cell carcinoma","volume":"119","author":"Lin","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib5","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1158\/1078-0432.CCR-09-2350","article-title":"Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence","volume":"16","author":"Maxwell","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1200\/JCO.2012.44.0164","article-title":"Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis","volume":"31","author":"O'Sullivan","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.oraloncology.2014.02.001","article-title":"Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer","volume":"50","author":"Vainshtein","year":"2014","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib8","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ijrobp.2015.08.033","article-title":"Phase 2 trial of de-intensified chemoradiation therapy for favorable-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma","volume":"93","author":"Chera","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib9","article-title":"Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: Where are we?","author":"Samuels","year":"2015","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib10","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ijrobp.2012.08.030","article-title":"Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: Prospective study of patient-reported, observer-rated, and objective outcomes","volume":"85","author":"Hunter","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib11","first-page":"35","article-title":"Assessment of three-dimensional set-up errors in head and neck cancer patients treated by intensity modulated radiotherapy using electronic portal imaging device","author":"Bayoumi","year":"2009","journal-title":"Gulf J Oncolog"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/1533034614561162","article-title":"Image guidance-based target volume margin expansion in imrt of head and neck cancer","volume":"15","author":"Srivastava","year":"2016","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib13","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.1120\/jacmp.v15i2.4418","article-title":"Assessment of setup uncertainties for various tumor sites when using daily CBCT for more than 2200 VMAT treatments","volume":"15","author":"Oh","year":"2014","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.radonc.2012.10.010","article-title":"Adaptive radiotherapy for head and neck cancer\u2014Dosimetric results from a prospective clinical trial","volume":"106","author":"Schwartz","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2013.10.010","article-title":"Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines","volume":"110","author":"Gregoire","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib16","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2307\/3583506","article-title":"Complication probability as assessed from dose-volume histograms","volume":"8","author":"Lyman","year":"1985","journal-title":"Radiat Res Suppl"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib17","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/0360-3016(89)90972-3","article-title":"Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method","volume":"16","author":"Kutcher","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijrobp.2009.07.1708","article-title":"Parotid gland function after radiotherapy: The combined michigan and utrecht experience","volume":"78","author":"Dijkema","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib19","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.ijrobp.2009.07.1685","article-title":"A comparison of dose-response models for the parotid gland in a large group of head-and-neck cancer patients","volume":"76","author":"Houweling","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00417897","article-title":"A penetration-aspiration scale","volume":"11","author":"Rosenbek","year":"1996","journal-title":"Dysphagia"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib21","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.ijrobp.2010.12.067","article-title":"Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: Swallowing organs late complication probabilities and dosimetric correlates","volume":"81","author":"Eisbruch","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ijrobp.2007.12.033","article-title":"Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy","volume":"72","author":"Murdoch-Kinch","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib23","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1245\/s10434-014-3656-z","article-title":"Minimal clinically important differences in quality of life scores of oral cavity and oropharynx cancer patients","volume":"21","author":"Binenbaum","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib24","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ijrobp.2011.08.017","article-title":"Adaptive radiotherapy for head-and-neck cancer: Initial clinical outcomes from a prospective trial","volume":"83","author":"Schwartz","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib25","unstructured":"NRG-HN002: A randomized phase II trial for patients with p16 positive, non-smoking associated locoregionally advanced oropharyngeal cancer, NCT02254278. Available at: https:\/\/www.Nrgoncology.Org\/clinical-trials\/nrg-hn002. Accessed May, 2015"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib26","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2013.31.15_suppl.6005","article-title":"ECOG 1308: A phase II trial of induction chemotherapy (IC) followed by cetuximab with low dose versus standard dose IMRT in patients with human papilloma virus (HPV)-associated resectable squamous cell carcinoma of the oropharynx (OPSCC)","volume":"31","author":"Marur","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib27","unstructured":"Clinicaltrials.Gov\u2014The quarterback trial: A randomized phase III clinical trial comparing reduced and standard radiation therapy doses for locally advanced HPV16 positive oropharynx cancer. Available at: http:\/\/clinicaltrials.Gov\/ct2\/show\/nct01706939. Accessed May, 2015"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib28","doi-asserted-by":"crossref","first-page":"e0152477","DOI":"10.1371\/journal.pone.0152477","article-title":"Robust intensity modulated proton therapy (IMPT) increases estimated clinical benefit in head and neck cancer patients","volume":"11","author":"van Dijk","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib29","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ijrobp.2016.02.021","article-title":"Clinical outcomes and patterns of disease recurrence after intensity modulated proton therapy for oropharyngeal squamous carcinoma","volume":"95","author":"Gunn","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib30","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1088\/0031-9155\/58\/11\/3563","article-title":"Probabilistic objective functions for margin-less IMRT planning","volume":"58","author":"Bohoslavsky","year":"2013","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2016.06.2456_bib31","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.radonc.2013.07.012","article-title":"An in silico comparison between margin-based and probabilistic target-planning approaches in head and neck cancer patients","volume":"109","author":"Fontanarosa","year":"2013","journal-title":"Radiother Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301616328073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301616328073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T09:33:06Z","timestamp":1601112786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301616328073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0360301616328073"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2016.06.2456","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methods for Reducing Normal Tissue Complication Probabilities in Oropharyngeal Cancer: Dose Reduction or Planning Target Volume Elimination","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2016.06.2456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}